Neuronetics Inc.(STIM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

STIM Neuronetics Inc.

Market Closed 11-06 16:00:00 EST

2.15

-0.28

-11.52%

盘后2.18

+0.03+1.23%

19:49 EST

High2.56	Low2.11	Vol3.66M
Open2.46	D1 Closing2.43	Amplitude18.31%
Mkt Cap167.12M	Tradable Cap83.17M	Total Shares77.73M
T/O8.49M	T/O Rate9.47%	Tradable Shares38.68M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"STIM","market":"US","secType":"STK","nameCN":"Neuronetics Inc.","latestPrice":2.15,"timestamp":1793998800000,"preClose":2.43,"halted":0,"volume":3664198,"hourTrading":{"tag":"盘后","latestPrice":2.1764,"preClose":2.15,"latestTime":"19:49 EST","volume":22513,"amount":48297.1306,"timestamp":1794012560072,"change":0.0264,"changeRate":0.012279,"amplitude":0.03707},"delay":0,"changeRate":-0.11522633744855977,"floatShares":38682300,"shares":77728300,"eps":-0.32245,"marketStatus":"Market Closed","change":-0.28,"latestTime":"11-06 16:00:00 EST","open":2.46,"high":2.555,"low":2.11,"amount":8492997.210835,"amplitude":0.183128,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.32245,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1530158400000,"exchange":"NASDAQ","adjPreClose":2.43,"preHourTrading":{"tag":"盘前","latestPrice":2.469,"preClose":2.43,"latestTime":"09:16 EST","volume":266,"amount":665.6986224,"timestamp":1793974605290,"change":0.039,"changeRate":0.016049,"amplitude":0.234568},"postHourTrading":{"tag":"盘后","latestPrice":2.1764,"preClose":2.15,"latestTime":"19:49 EST","volume":22513,"amount":48297.1306,"timestamp":1794012560072,"change":0.0264,"changeRate":0.012279,"amplitude":0.03707},"volumeRatio":1.6640635288684689,"impliedVol":1.7992,"impliedVolPercentile":0.7092},"requestUrl":"/m/hq/s/STIM/wiki","defaultTab":"wiki","newsList":[{"id":"2681867298","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2681867298","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681867298?lang=en_us&edition=fundamental","pubTime":"2026-11-06 22:41","pubTimestamp":1793976067,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neuronetics (STIM), Novavax (NVAX) and Trulieve Cann...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-405?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-405?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","LABU","STIM","BK4585","BK4547","LU0029874061.USD","BK4137","BK4139","HCSG","BK4082","LU0128526141.USD","NVAX","BK4588","BK4581","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681867645","title":"B. Riley Adjusts Price Target on Neuronetics to $6 From $5, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2681867645","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681867645?lang=en_us&edition=fundamental","pubTime":"2026-11-06 22:25","pubTimestamp":1793975130,"startTime":"0","endTime":"0","summary":"B. Riley Adjusts Price Target on Neuronetics to $6 From $5, Keeps Buy Rating","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["STIM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681861733","title":"Neuronetics, Inc. (NASDAQ:STIM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2681861733","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681861733?lang=en_us&edition=fundamental","pubTime":"2026-11-06 21:01","pubTimestamp":1793970093,"startTime":"0","endTime":"0","summary":"SSimply Wall StNovember 6, 2026","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6021000-choice2-card/1788934354473","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6021000-choice2-card/1788934354473"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-stim/neuronetics/news/neuronetics-inc-nasdaqstim-released-earnings-last-week-and-a","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-stim/neuronetics/news/neuronetics-inc-nasdaqstim-released-earnings-last-week-and-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["STIM",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681991830","title":"Neuronetics Grants Restricted Stock Units to 14 Non-Executive Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2681991830","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681991830?lang=en_us&edition=fundamental","pubTime":"2026-11-05 06:35","pubTimestamp":1793831704,"startTime":"0","endTime":"0","summary":"Neuronetics Grants Restricted Stock Units to 14 Non-Executive EmployeesNeuronetics today granted 123,300 restricted stock units to 14 non-executive employees under its 2020 Inducement Incentive Plan.A","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL3NB7jf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014005.SGD","BK4588","IE00B3QW5Z07.USD","STIM","LU0314104364.USD","LU2210150020.SGD","BK4112","IE00BGHQF748.EUR","LU2210149790.SGD","NDAQ","BCDF","BK4082","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4585","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014021.USD","SG9999014039.USD","IE00BKPKM429.USD","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","IE00BQXX3F31.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681098056","title":"Neuronetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2681098056","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681098056?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:30","pubTimestamp":1793827801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nTUA2XCZCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STIM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680684930","title":"Neuronetics Inc Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2680684930","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680684930?lang=en_us&edition=fundamental","pubTime":"2026-11-04 23:11","pubTimestamp":1793805080,"startTime":"0","endTime":"0","summary":"Neuronetics Inc reports results for the quarter ended September 30 - Earnings SummaryNeuronetics IncSTIM.OQreported a quarterly adjusted loss of 2 cents per share for the quarter ended September 30, h","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL5N46L2CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STIM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680051932","title":"Neuronetics Presents 2026 Revenue Guidance of $160 Million to $164 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680051932","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680051932?lang=en_us&edition=fundamental","pubTime":"2026-11-04 21:04","pubTimestamp":1793797465,"startTime":"0","endTime":"0","summary":"Neuronetics Presents 2026 Revenue Guidance of $160 Million to $164 MillionNeuronetics projects fiscal 2026 revenue of $160 million to $164 million, representing 7%-10% growth.Gross margin guidance is ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL44ZLVf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","STIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680051575","title":"Neuronetics Q3 Revenue Beats Estimates on Greenbrook Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2680051575","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680051575?lang=en_us&edition=fundamental","pubTime":"2026-11-04 21:01","pubTimestamp":1793797283,"startTime":"0","endTime":"0","summary":"Neuronetics Q3 revenue beats estimates on greenbrook growthOverviewU.S. interventional mental health firm's Q3 revenue rose 12.5%, beating analyst expectationsCompany's Q3 net loss narrowed from prior","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL2N46L0PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","STIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680592240","title":"Neuronetics Q3 EPS $(0.02) Beats $(0.09) Estimate, Sales $41.962M Beat $40.425M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2680592240","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680592240?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:53","pubTimestamp":1793796780,"startTime":"0","endTime":"0","summary":"Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.09) by 77.78 percent. This is a 84.62 percent increase over losses of $(0.13) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/62861127/neuronetics-q3-eps-0-02-beats-0-09-estimate-sales-41-962m-beat-40-425m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","STIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680105921","title":"Neuronetics Q3 Revenue USD 41.962 Million Vs. IBES Estimate USD 40.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680105921","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680105921?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:51","pubTimestamp":1793796661,"startTime":"0","endTime":"0","summary":"BRIEF-Neuronetics Q3 Revenue USD 41.962 Million Vs. IBES Estimate USD 40.4 MillionNov 04 (Reuters) - Neuronetics Q3 operating expenses USD 21.3 million.Q3 gross margin 52.2%Q3 EPS USD -0.02","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLXXQ6TND:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STIM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680286059","title":"Neuronetics Q3 2026 Net Loss Narrows 83% to $1.56 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680286059","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680286059?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:50","pubTimestamp":1793796650,"startTime":"0","endTime":"0","summary":"Neuronetics Q3 2026 net loss narrows 83% to $1.56 millionNeuronetics’ third-quarter 2026 net loss narrowed 83% year-over-year to $1.56 million.Total revenue rose 13% to $41.96 million, while Greenbroo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL16TmvG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","SG9999014013.SGD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","BK4585","IE00BN0W2V16.EUR","NDAQ","LU2095319765.USD","SG9999014039.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014005.SGD","BK4112","STIM","IE00BKPKM429.USD","BCDF","LU2210149790.SGD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4588","IE00B3QW5Z07.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680594740","title":"Neuronetics Q3 Operating Expenses USD 21.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680594740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680594740?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:50","pubTimestamp":1793796601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLXXQ6TND:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","STIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680477059","title":"Neuronetics Q3 Gross Margin 52.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680477059","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680477059?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:50","pubTimestamp":1793796601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLXXQ6TND:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","STIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680405929","title":"Neuronetics: 2026 Outlook Total Revenue Between $160 Mln-$164 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2680405929","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680405929?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:50","pubTimestamp":1793796601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLXXQ6TND:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","STIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680005947","title":"Neuronetics Q3 EPS USD -0.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2680005947","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680005947?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:50","pubTimestamp":1793796601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLXXQ6TND:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STIM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680059472","title":"Neuronetics Reports Third Quarter 2026 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2680059472","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680059472?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:50","pubTimestamp":1793796601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nTUA8LJCPH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","STIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677034679","title":"Neuronetics Publishes Update to Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2677034679","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677034679?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:30","pubTimestamp":1792585839,"startTime":"0","endTime":"0","summary":"Neuronetics Publishes Update to Financial CalendarNeuronetics will release third-quarter 2026 financial and operating results before market open on Wednesday, November 4, 2026.A conference call to rev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL4Hy6TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","BCDF","LU2210150020.SGD","IE00BN0W2W23.USD","BK4082","BK4585","IE00BQXX3F31.USD","LU2095319765.USD","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","BK4588","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014039.USD","STIM","IE00BN0W2T93.GBP","LU0314104364.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","BK4112","SG9999014005.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677671330","title":"Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2677671330","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677671330?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:30","pubTimestamp":1792585800,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Oct.  21, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar TMS technology with direct patient care through ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/21/3385514/0/en/neuronetics-to-report-third-quarter-2026-financial-and-operating-results-and-host-conference-call.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","TMS","BK4176","BK4082","STIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668940452","title":"Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668940452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668940452?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:50","pubTimestamp":1789728612,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB) w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neuronetics-stim-xenon-xene-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neuronetics-stim-xenon-xene-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4533","LU0320765992.SGD","LABU","HCSG","IE00B894F039.SGD","LU0128526141.USD","LU0029874061.USD","PBE","BK4082","SBIO","BK4532","BK4581","BK4588","XENE","BK4137","IE00B19Z9Z06.USD","BIIB","LU0889565916.HKD","BK4139","STIM","IBRN","LU0109394709.USD","LU0234570918.USD","IE00B19Z9P08.USD","XLV","BK4585","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999643","title":"Neuronetics Price Target Maintained with a $6.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999643","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999643?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:50","pubTimestamp":1789663800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/STIM/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","STIM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurostar.com","stockEarnings":[{"period":"1week","weight":-0.0444},{"period":"1month","weight":-0.0092},{"period":"3month","weight":-0.0966},{"period":"6month","weight":0.2991},{"period":"1year","weight":-0.1468},{"period":"ytd","weight":0.558}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.193879},{"month":2,"riseRate":0.25,"avgChangeRate":-0.0634},{"month":3,"riseRate":0.25,"avgChangeRate":-0.090432},{"month":4,"riseRate":0.5,"avgChangeRate":0.011631},{"month":5,"riseRate":0.375,"avgChangeRate":-0.092227},{"month":6,"riseRate":0.5,"avgChangeRate":-0.002416},{"month":7,"riseRate":0.555556,"avgChangeRate":0.12622},{"month":8,"riseRate":0.333333,"avgChangeRate":0.031062},{"month":9,"riseRate":0,"avgChangeRate":-0.136549},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.014996},{"month":11,"riseRate":0.333333,"avgChangeRate":0.069536},{"month":12,"riseRate":0.875,"avgChangeRate":0.223792}],"exchange":"NASDAQ","name":"Neuronetics Inc.","nameEN":"Neuronetics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neuronetics Inc.(STIM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Neuronetics Inc.(STIM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Neuronetics Inc.,STIM,Neuronetics Inc.股票,Neuronetics Inc.股票老虎,Neuronetics Inc.股票老虎国际,Neuronetics Inc.行情,Neuronetics Inc.股票行情,Neuronetics Inc.股价,Neuronetics Inc.股市,Neuronetics Inc.股票价格,Neuronetics Inc.股票交易,Neuronetics Inc.股票购买,Neuronetics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neuronetics Inc.(STIM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Neuronetics Inc.(STIM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}